Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Precision Medicine for Heart Failure with Preserved Ejection Fraction: An Overview.

Journal of cardiovascular translational research - 1 Jun 2017

Shah Sanjiv J

Abstract excerpt

There are few proven therapies for heart failure with preserved ejection fraction (HFpEF). The lack of therapies, along with increased recognition of the disorder and its underlying pathophysiology, has led to the acknowledgement that HFpEF is heterogeneous and is not likely to respond to a one-size-fits-all approach. Thus, HFpEF is a prime candidate to benefit from a precision medicine approach. For this reason,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiovascular Agents
Share to Comorbidity
Share to Heart Failure

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Machine Learning

Share to Molecular Diagnostic Techniques

Share to Precision Medicine

Share to Stroke Volume

Share to Systems Biology

Source

Open in PubMed Open full text

Identifiers

PMID: 28585183
DOI: 10.1007/s12265-017-9756-y
PMCID: PMC5540576

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Precision Medicine for Heart Failure with Preserved Ejection Fraction: An Overview.PMID 28585183Read ↗

The future of heart failure with preserved ejection fraction : Deep phenotyping for targeted therapeutics.Semantic proximity Read ↗

Heart Failure in the Era of Precision Medicine: A Scientific Statement From the American Heart AssociationSemantic proximity Read ↗

Towards Precision in HF Pharmacotherapy.Semantic proximity Read ↗

Phenotypic spectrum of heart failure with preserved ejection fraction.Semantic proximity Read ↗

Clinical Phenogroups in Heart Failure with Preserved Ejection Fraction.Semantic proximity Read ↗

Heart Failure with Preserved Ejection Fraction: The Pathophysiological Mechanisms behind the Clinical Phenotypes and the Therapeutic Approach.Semantic proximity Read ↗

Heart failure with preserved ejection fraction: Classification based upon phenotype is essential for diagnosis and treatment.Semantic proximity Read ↗

Heart failure with non-reduced ejection fraction: Epidemiology, pathophysiology, phenotypes, diagnosis and treatment approaches.Semantic proximity Read ↗

Echocardiographic Phenomapping in HFpEF: From Imaging Biomarkers to Precision Cardiovascular Medicine.Semantic proximity Read ↗

Key Phenotypes of Heart Failure with Preserved Ejection Fraction: Pathophysiologic Mechanisms and Potential Treatment Strategies.Semantic proximity Read ↗

Large-scale multi-omics identifies drug targets for heart failure with reduced and preserved ejection fraction.Semantic proximity Read ↗

Towards a phenotype profiling of the patients with heart failure and preserved ejection fractionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.